Efficacy and Safety of Bovine Intestinal Alkaline Phosphatase (bIAP) During Heart Surgery
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This multi-centre prospective, randomised, double-blind, placebo-controlled study is designed
to evaluate the efficacy and safety of bovine intestinal alkaline phosphatase (bIAP) in
reducing the pro-inflammatory post-surgical responses and thereby preserving organ functions
in patients undergoing invasive cardiac surgery: combined aortic valve replacement and
coronary artery bypass grafting.